Image (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 01)
Chlorpromazine Hydrochloride Tablet, Film Coated
Product Images NDC 70710-1129
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 70710-1129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 02)
Chlorpromazine Hydrochloride tablets are a prescription drug used to treat various mental disorders. These tablets contain 10mg of Chlorpromazine Hydrochloride, USP per film-coated tablet. The recommended dosage can be found in the package insert. These tablets should be stored at room temperature and protected from light and moisture. They must be dispensed in a tight, light-resistant container with a child-resistant closure. Cadia Healthcare Ltd, India manufactures these tablets, which are distributed by 2Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*
Carton (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 03)
This is a description of Chlorpromazine Hydrochloride Tablets, USP. These tablets are used for their usual dosage as mentioned in the package insert for complete prescribing information. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) and protected from light and moisture. The closed, light-resistant, and child-resistant container should be utilized. These tablets are distributed by Zydus Pharmaceuticals (USA) Inc in unit dose packages containing 100 tablets each.*
Label (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 04)
NDC 70710-41304 is a drug containing Chlorpromazine hydrochloride, generally taken as per the instructions given in the package insert. The tablets should be stored at temperatures ranging from 20 to 25°C, protected from light and moisture, and dispensed in a tightly-closed, light-resistant container as defined in the USP. It is important to keep this medication and all drugs out of the reach of children. Cadila Healthcare Ltd., India, is the manufacturer of this drug presented in a pack of 100 tablets, available only through a prescription from an authorized healthcare professional.*
Carton (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 05)
This is a description of chlorpromazine hydrochloride tablets, manufactured by Cadila Healthcare Limited, India and distributed by Zydus Pharmaceuticals (USA) Inc. The tablets come in 100 count pack sizes and contain 25 mg of chlorpromazine hydrochloride per film-coated tablet. The recommended dosage is available in the package insert. Storage information and cautionary instructions for dispensing have been provided. The National Drug Code for the product is 70710-1130-4.*
Label (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 06)
Description:
This is a medication information label for ChlorproMAZINE St wm tablets. It includes the NDCTOT number and highlights the usual dosage details along with storage instructions. The manufacturer and distributor details are also provided.*
Carton (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 07)
This is a drug package label for ChlorproMAZINE Hydrochloride tablets. It includes the dosage information, storage instructions, and the name of the manufacturer and distributor. It also warns to keep this and all drugs out of the reach of children.*
Label (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 08)
The text describes Chlorpromazine HCL tablets used in severe neuropsychiatric conditions with a dosage prescribed through a package insert. It advises storing the tablets at controlled room temperature and protecting them from light and moisture. The tablets are manufactured in India and distributed by Zydus Pharmaceuticals in the USA. It also contains warnings to keep the drug out of reach of children and dispensing the tablets in a child-resistant container.*
Carton (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 09)
This text appears to describe a medication called Chlorpromazine Hydrochloride, which is available in the form of 100 tablets. The medication has an NDC number of 70710-11324 and is manufactured by Caiia Healthcare Ltd. in India. It is distributed in the US by Zydus Pharmaceuticals (USA) Inc. The described medication is only used for severe neuropsychiatric conditions, and exact dosage should be taken according to the package insert. The manufacturer recommends storing the medication at 20°C to 25°C and protecting it from light and moisture. There is also a warning to keep the medication out of reach of children.*
Label (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 10)
Chlorpromazine Hydrochloride Tablets, USP with 200mg strength are recommended only for severe neuropsychiatric conditions. The package insert for complete prescribing information should be consulted for the usual dosage. The tablets should be stored at controlled room temperature between 20° to 25°C (68° to 77°F) protecting them from light and moisture. They should be kept in a chi-resistant closure container that restricts light. HPITT204 2 is the code for the medicine manufactured by Gadia Healthcare Ltd in India and is distributed by Zydus Pharmaceuticals (USA) Inc. located in Pennington, NJ 08534. Keep all medications out of the reach of children.*
Carton (A6bd2d53 Fed8 4acf Be24 32ed207c3f1b 11)
ChlorproMAZINE Hydrochloride is a strong medication used to treat severe neuropsychiatric conditions. It is available in tablet form, with each film-coated tablet containing 200mg of ChlorproMAZINE Hydrochloride. This medication is not for household dispensing and must be kept out of reach of children. It should be stored in a closed, light-resistant, child-resistant container between 20-25°C. The packaging contains complete prescribing information, and the drug is manufactured and distributed by Caia Healthcare Ltd., India, and Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
